Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma

Published:2024-03-20 Issue: Volume: Page:1-14
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Umar Hassaan¹,Wahab Habibah A.¹,Ahmed Nadeem²,Fujimura Nao Akusa²,Amjad Muhammad Wahab³,Bukhari Syed Nasir Abbas⁴,Ahmad Waqas¹

Affiliation:

1. School of Pharmaceutical Science, Universiti Sains Malaysia, Minden, Malaysia

2. CEMB, Lahore, Pakistan

3. Center for Ultrasound Molecular Imaging and Therapeutics, Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, USA

4. Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Aljouf, Saudi Arabia

Funder

Universiti Sains Malaysia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2024.2326043

Reference56 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;Cancer J Clin,2021

2. Global Patterns and Trends in Lung Cancer Incidence: A Population-Based Study

3. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

4. Economic burden of cancer across the European Union: a population-based cost analysis

5. The Discovery and Development of Cisplatin

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP